The cost-effectiveness of therapies to treat alcohol use disorders

被引:18
|
作者
Rehm, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Barbosa, C. [8 ]
机构
[1] Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, Toronto, ON, Canada
[2] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada
[3] Univ Toronto, Dalla Lana Sch Publ Hlth, Addict Policy, Toronto, ON, Canada
[4] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada
[5] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[6] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany
[7] Tech Univ Dresden, Ctr Clin Epidemiol & Longitudinal Studies CELOS, Dresden, Germany
[8] RTI Int, Behav Hlth & Criminal Justice Div, Chicago, IL USA
关键词
Alcohol; alcohol use disorders; therapy; behavioral intervention; pharmaceutical intervention; brief intervention; cost-effectiveness; cost-benefit analysis; economic analysis; PRIMARY-HEALTH-CARE; COGNITIVE-BEHAVIORAL THERAPY; BRIEF INTERVENTIONS; GLOBAL BURDEN; TREATMENT SBIRT; DOUBLE-BLIND; DEPENDENCE; CONSUMPTION; MISUSE; ACAMPROSATE;
D O I
10.1080/14737167.2018.1392241
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: Alcohol use is a major risk factor for mortality and morbidity burden, and alcohol use disorders contribute markedly to this burden. Effective interventions for alcohol use disorders improve health, and are potentially cost-effective or even cost saving. Areas covered: We searched the literature for the cost-effectiveness of alcohol interventions. We included behavioral, pharmacological and combined interventions, and research from both a health care provider and a societal perspective. Overall, many economic research studies pointed towards existing cost-beneficial therapies from the perspective of a health care provider; i.e. the costs for interventions were smaller than the savings in services delivery in the years thereafter. Even if this was not the case, the interventions proved to be cost-effective with a threshold below $ 20,000 per quality-adjusted life year. Expert Commentary: While most of the economic research to date shows promising results, such research is relatively scarce and not always rigorous. More, and more rigorous economic research is needed to fully understand the potential impact of alcohol interventions. However, even with this research, something needs to be done to reduce stigmatization of alcohol use disorders in order to fully reap the benefits of alcohol interventions.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 50 条
  • [21] Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease
    Antonio Di Sabatino
    Lucio Liberato
    Monia Marchetti
    Paolo Biancheri
    Gino R. Corazza
    Internal and Emergency Medicine, 2011, 6
  • [22] Cost-effectiveness of novel therapies for overactive bladder
    Mayr, Craig A.
    Shepherd, Jonathan P.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (04) : 527 - 535
  • [23] Assessing the cost-effectiveness of emerging therapies in the ICU
    Chalfin, DB
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 20 (03) : 263 - 270
  • [24] A cost-effectiveness analysis of oral triptan therapies
    Yalkowsky, RB
    Malone, DC
    VALUE IN HEALTH, 2002, 5 (06) : 455 - 455
  • [25] PRESSURE TO TREAT AND PRESSURE TO COST - A REVIEW OF COST-EFFECTIVENESS ANALYSIS
    FLETCHER, A
    JOURNAL OF HYPERTENSION, 1991, 9 (03) : 193 - 198
  • [26] Cost-effectiveness analysis of current therapies for melasma
    Piacquadio, DJ
    Smith, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P175 - P175
  • [27] Cost-Effectiveness of Biologic Therapies in Asthma in Spain
    Martinez-Moragon, Eva
    ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (10): : 621 - 622
  • [28] Cost-effectiveness of Alprazolam in anxiety disorders
    Garcia-Contreras, F
    Castro-Ríos, A
    Nevarez-Sida, A
    Constantino-Casas, P
    Contreras-Hernández, I
    Mould, J
    Garduño-Espinosa, J
    VALUE IN HEALTH, 2005, 8 (03) : 385 - 386
  • [29] COST-EFFECTIVENESS OF ANTIBIOTIC USE
    ALDIS, WL
    COWAN, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (23): : 3252 - 3252
  • [30] The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis
    Wailoo, Allan
    Hock, Emma S.
    Stevenson, Matt
    Martyn-St James, Marrissa
    Rawdin, Andrew
    Simpson, Emma
    Wong, Ruth
    Dracup, Naila
    Scott, David L.
    Young, Adam
    HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (71) : 1 - +